Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
July 24, 2026
A Delaware bankruptcy judge has signed off on a deal resolving a $28.3 million claim by the buyer of defunct drug developer Akorn's assets, allowing an $18.5 million claim in the Chapter 7 case.
-
July 23, 2026
A Texas appellate court overturned a temporary injunction against a licensed Houston-area midwife accused by state prosecutors of violating Texas' abortion ban, finding Thursday a trial court wrongly admitted probable-cause affidavits from a related criminal case.
-
July 23, 2026
The Tenth Circuit on Thursday overturned a lower court ruling that AstraZeneca lacked immunity from an experimental COVID-19 vaccine trial participant's lawsuit seeking medical compensation after she suffered debilitating injuries, saying a federal statute providing immunity for vaccine developers covers her contract breach claims.
-
July 23, 2026
Abbott Laboratories and Exact Sciences were hit with a proposed class action in Illinois federal court Wednesday over a cyberattack carried out by a notorious ransomware gang known as "Shinyhunters" that absconded with patients' medical records, which the suit says is far more harmful than standard identity theft.
-
July 23, 2026
A Missouri appellate court upheld a win for a group of insurers on their arguments that a "your products" policy exclusion applied to bar coverage of alleged damages from drugmaker Mallinckrodt's unbranded marketing of opioid products.
See more Life Sciences news